Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,316,748
+$1,130,665 QoQ
Shares Held
3,599
+3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#1,827
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $41,817,560 across 12 Drug Manufacturers - General names. LLY ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,724 | $28,882,484 | |
| 2 | ABBV |
AbbVie Inc.
|
21,140 | $5,319,669 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
3,599 | $4,316,748 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,886 | $1,141,851 | |
| 5 | PFE |
Pfizer Inc
|
30,849 | $742,843 | |
| 6 | AMGN |
Amgen Inc
|
1,750 | $633,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,641 | $267,414 | |
| 8 | GSK |
GSK plc
|
4,548 | $238,406 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,316,748 | 3,599 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,186,083 | 3,464 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,966,644 | 3,691 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,773,505 | 3,635 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,832,812 | 3,634 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,003,008 | 3,636 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,701,228 | 3,499 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $3,082,185 | 3,479 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $3,104,548 | 3,429 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,526,036 | 3,247 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $1,770,910 | 3,038 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $1,716,667 | 3,196 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $2,064,449 | 4,402 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $1,479,796 | 4,309 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $1,259,952 | 3,444 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $712,986 | 2,205 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $314,178 | 969 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $261,169 | 912 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $253,846 | 919 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $226,660 | 981 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $200,830 | 875 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $163,467 | 875 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $136,760 | 810 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $118,267 | 799 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $132,657 | 808 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $111,669 | 805 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||